Gene Analysis
Gene Analysis is the Exclusive Distributor of Myriad Genetics for Greece, Cyprus, Serbia, Slovenia, Bosnia & Herzegovina, Montenegro, Albania, Former Yugoslav Republic of Macedonia, Kosovo, Croatia and other jurisdictions.
Gene Analysis collaborates with an extensive network of laboratories and healthcare providers, offering to the patients the to take the benefits of Myriad Genetics testing.
EndoPredict® Reimbursement E.O.P.Y.Y.
According published F.E.K. (4455 of 8th October 2020, B’ edition), EndoPredict® is reimbursed for Breast Cancer patients by E.O.P.Y.Y. under the following clinical indications:
- Positive Estrogen Receptors (ER+)
- Negative ΗER2/neu
- Pre-menauposal and Post-menauposal patients
- Negative or 3 positive lymph nodes
- Clinical Stage 1-3
- Tumor Size pT1-4
Patient’s out of pocket cost, 15%, is 315€.
Please contact us for more information.
Contact us for more information.
Our Services
About Us Myriad Genetics
Founded in 1991, Myriad was one of the first genomic companies, driven by the vision of elucidating the role genes play in human disease and using this critical information to improve patient care by developing novel molecular diagnostic products.
1 +
Years in Business
1 +
Employees
1
Different Specialties
1
Products
Amazing Feedback
Latest News & Articles
News from ASCO 2021
Myriad Launches riskScore™ Beginning the Next Epoch in Hereditary Cancer Testing
